EARLY HEARING DETECTION AND INTERVENTION VIRTUAL CONFERENCE
MARCH 2-5, 2021
(Virtually the same conference, without elevators, airplane tickets, or hotel room keys)
9/25/2018 | 2:00 PM - 2:30 PM | Engaging Patients in Obstetric Care Provider Guidelines: Canadian Experience Opportunities Patient-Oriented Research | Emerald Ballroom I/II
Engaging Patients in Obstetric Care Provider Guidelines: Canadian Experience Opportunities Patient-Oriented Research
The Society of Obstetricians & Gyneacologists of Canada (SOGC) publishes evidence-based national clinical practice guidelines for obstetric care providers. These clinical practice guidelines are widely used by a different OB care providers including midwives, obstetricians, nurse practitioners, perinatologists and family physicians. Current SOGC’s CMV Infection in Pregnancy Guideline dates from 2010; it was aimed to review the principles of CMV prenatal diagnosis and to describe the outcomes of affected pregnancies. A 2018 CMV in Pregnancy Guideline update is underway to reflect emerging data on the risk of congenital CMV infection according to maternal serostatus, treatment of congenitally infected babies, cost effectiveness of congenital CMV screening and prevention strategies. Urgency to update this guideline in driven by the fact that Canada’s largest province, Ontario (N= 180,000 annual births) will implement universal screening for congenital CMV infection in 2019. It is expected that every year, at least 800 families in Ontario will become aware of having a child affected by congenital CMV infection within a few weeks of birth. There are obvious implications to Ontario obstetric care providers: updating this guideline is one step to improve their CMV-related knowledge especially as it pertains to the rational behind recommending against maternal screening during pregnancy and prevention strategies to be discussed with patients. This presentation will describe SOGC experience incorporating patients on CMV infection in pregnancy clinical guideline development and dissemination. Recognizing priorities of patients should be used to guide practice, especially in light of difficulties posed by congenital CMV infection.
- Describe Canadian CMV Infection in Pregnancy OB Care Provider Clinical Guideline Approach
- Describe current level of patient engagement on evidence-based national clinical practice guidelines for obstetric care providers
- Discuss reasons to include patients in CMV Infection in Pregnancy Provider Guidelines Development and Dissemination
Presentation:
This presentation has not yet been uploaded.
Handouts:
Handout is not Available
Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
Eliana Castillo
(), castillo@ucalgary.ca;
Dr. Eliana Castillo is Clinical Associate Professor at the University of Calgary, where her medical and teaching practice focuses on medical disorders in pregnancy and maternal infections. She has been active in the area of immunization during pregnancy, congenital CMV infection and maternal mortality at a local and national level through her work with the Society of Obstetrics and Gyneacologists of Canada, Alberta Perinatal Health Program and National Advisory Committee for Immunization.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
Maria Santana
(), mjsantan@ucalgary.ca;
Dr. Maria Santana holds a PhD in Public Health Sciences from the University of Alberta. She was previously the Associate Director for both the Alberta Strategy for Patient-Oriented Research (SPOR) Methods Support and Development Platform, as well as The Methods Hub at the O'Brien Institute for Public Health at the University of Calgary.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
Lisa Robinson
(), play-on-words@hotmail.com;
Speech Language Pathologist
Mother
ASHA DISCLOSURE:
Financial -
Nonfinancial -
Rob Tetrault
(), rtetrault@cgf.com;
Founder CMV Canada Foundation
ASHA DISCLOSURE:
Financial -
Nonfinancial -